592849
research-article2015
JETXXX10.1177/1526602815592849Journal of Endovascular TherapyLeung et al.
Clinical Investigation
Rheolytic Pharmacomechanical Thrombectomy for the Management of Acute Limb Ischemia: Results From the PEARL Registry
Journal of Endovascular Therapy 1–12 © The Author(s) 2015 Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/1526602815592849 www.jevt.org
Daniel A. Leung, MD1, Lawrence R. Blitz, MD2, Teresa Nelson, MS3, Ali Amin, MD, RVT4, Peter A. Soukas, MD5, Aravinda Nanjundappa, MD, RVT6, Mark J. Garcia, MD1, Robert Lookstein, MD7, and Eugene J. Simoni, MD8
Abstract Purpose: To present the results of rheolytic pharmacomechanical thrombectomy (PMT) for the management of acute limb ischemia (ALI) as reported in the PEARL Registry (PEripheral Use of AngioJet Rheolytic Thrombectomy with a variety of catheter Lengths). Methods: A total of 283 patients (mean age 65±13 years; 170 men) presenting with ALI undergoing treatment with the AngioJet System at participating institutions were enrolled in the registry. Rutherford ALI categories included 26% with viable limbs, 38% with marginally threatened limbs, 35% with immediately threatened limbs, and
research-article2015
JETXXX10.1177/1526602815592849Journal of Endovascular TherapyLeung et al.
Clinical Investigation
Rheolytic Pharmacomechanical Thrombectomy for the Management of Acute Limb Ischemia: Results From the PEARL Registry
Journal of Endovascular Therapy 1–12 © The Author(s) 2015 Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/1526602815592849 www.jevt.org
Daniel A. Leung, MD1, Lawrence R. Blitz, MD2, Teresa Nelson, MS3, Ali Amin, MD, RVT4, Peter A. Soukas, MD5, Aravinda Nanjundappa, MD, RVT6, Mark J. Garcia, MD1, Robert Lookstein, MD7, and Eugene J. Simoni, MD8
Abstract Purpose: To present the results of rheolytic pharmacomechanical thrombectomy (PMT) for the management of acute limb ischemia (ALI) as reported in the PEARL Registry (PEripheral Use of AngioJet Rheolytic Thrombectomy with a variety of catheter Lengths). Methods: A total of 283 patients (mean age 65±13 years; 170 men) presenting with ALI undergoing treatment with the AngioJet System at participating institutions were enrolled in the registry. Rutherford ALI categories included 26% with viable limbs, 38% with marginally threatened limbs, 35% with immediately threatened limbs, and
